Bristol-Myers Squibb
BMY
#190
Rank
S$137.03 B
Marketcap
S$67.31
Share price
1.94%
Change (1 day)
-11.13%
Change (1 year)

Bristol-Myers Squibb (BMY) - Cash on Hand

Cash on Hand as of September 2025 : S$21.38 Billion

According to Bristol-Myers Squibb's latest financial reports the company has S$21.38 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Bristol-Myers Squibb - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$14.76 B-8.99%
2023-12-31S$16.21 B30.74%
2022-12-31S$12.40 B-46.72%
2021-12-31S$23.28 B6.98%
2020-12-31S$21.76 B4.87%
2019-12-31S$20.75 B73.43%
2018-12-31S$11.96 B31.34%
2017-12-31S$9.11 B-0.86%
2016-12-31S$9.19 B52.16%
2015-12-31S$6.04 B-38.52%
2014-12-31S$9.82 B71.36%
2013-12-31S$5.73 B65.72%
2012-12-31S$3.45 B-69.41%
2011-12-31S$11.30 B20.26%
2010-12-31S$9.40 B-21.32%
2009-12-31S$11.95 B1.13%
2008-12-31S$11.81 B269.16%
2007-12-31S$3.20 B-47.97%
2006-12-31S$6.15 B-36.27%
2005-12-31S$9.65 B-20.81%
2004-12-31S$12.19 B29.03%
2003-12-31S$9.44 B36.53%
2002-12-31S$6.92 B-33.87%
2001-12-31S$10.46 B78.41%
2000-12-31S$5.86 B19.16%
1999-12-31S$4.92 B32.89%
1998-12-31S$3.70 B50.92%
1997-12-31S$2.45 B4.35%
1996-12-31S$2.35 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
S$19.41 B-9.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$23.60 B 10.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$12.84 B-39.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$12.63 B-40.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
S$13.54 B-36.66%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
S$10.60 B-50.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
S$24.05 B 12.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$7.34 B-65.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$12.23 B-42.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$5.13 B-76.00%๐Ÿ‡บ๐Ÿ‡ธ USA